|
Delayed
Nasdaq Stockholm
15:30:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.673 SEK | -2.22% |
|
-1.01% | -65.18% |
| 10-15 | Two Sigma Investments becomes a new public short seller in Oncopeptides | FW |
| 10-14 | Mixed close on Stockholm exchange, SEB fell on higher capital requirements | FW |
| Market Cap | 676M 68.6M 61.45M 56.69M 51.3M 95.93M 6.53B 97.48M 270M 3.42B 257M 252M 10.83B | P/E 2026 * |
-3.6x | P/E 2027 * | -7.6x |
|---|---|---|---|---|---|
| Enterprise Value | 730M 74.08M 66.35M 61.22M 55.4M 104M 7.05B 105M 291M 3.69B 278M 272M 11.69B | EV / Sales 2026 * |
5.66x | EV / Sales 2027 * | 2.96x |
| Free-Float |
96.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ONCO | Delayed | |
CBOE
| ONCOs | Real-time | |
|
Deutsche Boerse AG
| OND | Delayed | |
|
London S.E.
| 0RN4 | Delayed | |
|
CBOE
| 0RN4 | Real-time | |
|
Börse Stuttgart
| OND | Delayed | |
|
Boerse Muenchen
| OND | Real-time |
Last Transcript: Oncopeptides AB
| 1 day | -2.40% | ||
| 1 week | -1.01% | ||
| Current month | -23.47% | ||
| 1 month | -23.47% | ||
| 3 months | +5.62% | ||
| 6 months | +28.30% | ||
| Current year | -65.18% |
| 1 week | 1.62 |  | 1.76 |
| 1 month | 1.62 | | 3.18 |
| Current year | 1.26 | | 4.91 |
| 1 year | 1.26 | | 6.14 |
| 3 years | 1.1 | | 9.4 |
| 5 years | 1.1 | | 50.84 |
| 10 years | 1.1 | | 215 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Heigis
CEO | Chief Executive Officer | 46 | 07/08/2023 |
| Director of Finance/CFO | 52 | 13/11/2023 | |
Stefan Norin
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 01/01/2012 | |
| Director/Board Member | 63 | 01/02/2017 | |
Per Wold-Olsen
CHM | Chairman | 78 | 17/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 A | Free | Chief Technology Officer | 3,000 | 0.0008% | ||
| 3/18/26 A | Buy | 14,631 | 0.0038% | |||
| 3/17/26 A | Free | Investor Relations Manager | 66 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22% | -1.01% | -70.07% | -76.53% | 68.6M | |
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +1.37% | +4.32% | +16.17% | +86.56% | 56.16B | |
| +0.73% | +2.31% | +15.76% | +107.51% | 54.16B | |
| -2.49% | -3.52% | +24.51% | +52.14% | 45.33B | |
| +0.46% | -1.04% | +21.24% | +100.25% | 42.25B | |
| -0.27% | +1.68% | +222.96% | +936.10% | 40.78B | |
| +3.18% | +47.50% | +112.01% | +95.88% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | +0.01% | +4.57% | +41.14% | +140.21% | 39.27B | |
| Weighted average by Cap. | +0.25% | +3.64% | +50.34% | +162.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 13.08M 11.72M 10.81M 9.78M 18.29M 1.25B 18.59M 51.45M 652M 49.09M 48.05M 2.06B | 252M 25.53M 22.87M 21.1M 19.09M 35.7M 2.43B 36.28M 100M 1.27B 95.83M 93.79M 4.03B |
| Net income | -167M -16.89M -15.13M -13.96M -12.63M -23.62M -1.61B -24M -66.44M -842M -63.39M -62.05M -2.67B | -62.47M -6.34M -5.68M -5.24M -4.74M -8.86M -603M -9M -24.92M -316M -23.78M -23.27M -1B |
| Net Debt | 54M 5.48M 4.91M 4.53M 4.1M 7.66M 522M 7.78M 21.54M 273M 20.56M 20.12M 865M | 68M 6.9M 6.18M 5.7M 5.16M 9.64M 657M 9.8M 27.13M 344M 25.89M 25.33M 1.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | SEK 1.673 | -2.22% | 3,172,990 |
| 29/10/26 | SEK 1.711 | +3.07% | 5,456,783 |
| 28/10/26 | SEK 1.660 | 0.00% | 2,392,687 |
| 27/10/26 | SEK 1.660 | -0.60% | 2,994,287 |
| 26/10/26 | SEK 1.670 | -1.18% | 2,704,963 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions
